IndraLab

Statements

Peptide inhibits USP22. 2 / 2

| 1 1

eidos

"Cells treated with the cyclic peptide inhibitors had increased H2B-Ub levels , indicating that the peptides can also inhibit USP22 in vivo ."

34936860

➶

reach

"Macrocyclic peptide inhibitors of USP22 have been developed by Morgan et al. (53) with one representative named hD1 ( Figure 8D , compound 19)."

36465350

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Peptide inhibits USP22. 2 / 2

INDRA sources:

Databases

Reading